← Back to Clinical Trials
Recruiting NCT06913270

NCT06913270 Virtual Reality Adjunct for Procedural Pain and Anxiety Management in Burn Wound Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06913270
Status Recruiting
Phase
Sponsor Al Hayah University In Cairo
Condition Burns
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-04-12
Primary Completion 2026-05-25

Trial Parameters

Condition Burns
Sponsor Al Hayah University In Cairo
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2025-04-12
Completion 2026-05-25
Interventions
Immersive Virtual Reality Distraction (IVRD)Nature Video Distraction (NVD)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This randomized controlled trial is designed to evaluate the efficacy of immersive virtual reality (VR) as an adjunct to standard analgesia during dressing changes in adult burn patients. The study compares an intervention group receiving standard care combined with an immersive VR distraction (using a head-mounted display displaying an engaging virtual environment) versus a control group receiving standard care plus non-VR distraction (watching a nature video on a tablet). The primary outcomes include procedural pain intensity measured by the Visual Analog Scale (VAS) and anxiety levels measured by the State-Trait Anxiety Inventory (STAI). Secondary outcomes include patient satisfaction and physiological parameters (heart rate and blood pressure) recorded during the procedure. This trial addresses the critical gap of heterogeneity and small sample sizes noted in previous VR studies for burn care pain management (Dascal et al., 2017).

Eligibility Criteria

Inclusion Criteria: Adult burn patients (18-65 years) with confirmed partial-thickness burns. Scheduled for routine dressing changes. Able to provide informed consent. Baseline pain score of ≥4/10 during a dressing change session. Exclusion Criteria: Patients with cognitive impairment preventing comprehension of the intervention. History of severe motion sickness or visual impairments that preclude the use of VR devices. Patients with contraindications to standard analgesic care.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology